• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Republican congressman will end monthslong absence from DC after missing 135 roll call votes

by June 19, 2026
written by June 19, 2026

After more than 100 days away from Capitol Hill, Rep. Tom Kean Jr., R-N.J., is set to return to Washington, D.C., in the coming weeks.

Kean, 57, will be present for votes during the June 30 session, a spokesperson for the congressman confirmed to Fox News Digital. The two-term New Jersey lawmaker has been sidelined for months with a personal health issue and has yet to disclose the nature of the ailment. 

Kean has pledged to be transparent about his illness once he is back in Washington.

The New Jersey Globe first reported the timing of Kean’s expected return. He previously told the outlet his medical issue did not affect his cognitive health and will not have any chronic complications that could impair his ability to seek a third House term.

HOUSE REPUBLICAN MISSES ANOTHER WEEK OF VOTES AS HEALTH ABSENCE STRAINS THIN MAJORITY

The embattled lawmaker has not been seen in public or cast a vote on the House floor since early March, amounting to 135 missed roll call votes, according to GovTrack.

Kean’s office has still continued to introduce legislation and post on social media. 

The New Jersey Republican’s expected return to Washington ahead of November’s midterm elections will be relatively short-lived. With just over 30 legislative days remaining, lawmakers are scheduled to spend nearly all of August and October back home campaigning for re-election. 

DEMS PICK CHALLENGER FOR GOP CONGRESSMAN WHO VANISHED FROM PUBLIC VIEW AMID HEALTH MYSTERY

Thursday’s announcement comes as Kean is facing a significant reelection challenge from former Navy helicopter pilot Rebecca Bennett in one of the country’s most competitive House battleground districts.

Bennett, who is expected to lean into her national security background on the campaign trail, defeated several Democrat primary challengers in May to advance to the general election.

She has largely refrained from criticizing Kean during his absence but said he must be transparent with voters about his health issue.

Kean, who has the endorsement of President Donald Trump, ran unopposed for the GOP nomination, but his future in Congress remains unclear amid his absence and health concerns. 

The nonpartisan Cook Political Report rates the New Jersey contest in the suburban swing seat as a “toss-up.”

<!–>

–>

0 comment
0
FacebookTwitterPinterestEmail

previous post
Cathie Wood buys more Tesla, cuts Roku as ARK doubles down on AI
next post
Walz approval rating craters to lowest level ever and trails Trump amid massive fraud scandal: ‘Tired of it’

related articles

WATCH: Would-be second-term President Biden left searching for...

June 19, 2026

Gabbard spotlights Fauci, COVID-origin questions in final act...

June 19, 2026

DOJ warns former red state is becoming the...

June 19, 2026

New poll reveals Americans see two paths on...

June 19, 2026

Israel–Hezbollah ceasefire becomes first test of Trump Iran...

June 19, 2026

Dem justices slap Soros-backed Philly DA with power...

June 19, 2026

Trump leaves Netanyahu endorsement hanging with pointed warning...

June 19, 2026

Gov Sanders reveals ‘major breakthrough’ on education as...

June 19, 2026

Walz approval rating craters to lowest level ever...

June 19, 2026

Socialist Surge: Mamdani flexes growing political muscle as...

June 18, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • UFO whistleblower claims billions in secret spending hidden from Congress

    June 10, 2026
  • Dow futures rise 300 points: 5 things to know before Wall Street opens

    June 12, 2026
  • Stocks sink as worries about an interest rate hike rattle tech investors

    June 6, 2026
  • Dow rises 250 points as Iran deal hopes grow ahead of SpaceX debut

    June 12, 2026
  • Trump’s SAVE America Act shows signs of life in the Senate despite Republican revolt

    June 9, 2026

Popular Posts

  • 1

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 2

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 3

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 4

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 5

    DocuSign stock falls as cautious outlook overshadows earnings beat

    June 5, 2026

Categories

  • Editor's Pick (123)
  • Investing (315)
  • Stock (20)

Latest Posts

  • FTSE 100 slides as Fed outlook and sector losses weigh on markets

    June 18, 2026
  • NYC Mayor Zohran Mamdani says the Democratic Party ‘lost its focus on working people’

    June 8, 2026
  • California election limbo fueled by 4 pressure points dragging out vote count, expert says

    June 5, 2026

Recent Posts

  • USD/JPY forecast as Goldman Sachs turns bullish on the Indian rupee

    June 8, 2026
  • Dow gains 270 points as chip stocks rally, oil prices retreat

    June 9, 2026
  • Iran’s regime spins nuclear and Strait of Hormuz deal with Trump as victory over US, Israel

    June 15, 2026

Editor’s Pick

  • Robinhood stock gains as analysts back growth despite layoffs

    June 17, 2026
  • London’s FTSE 100 falls as GSK slides after Nuvalent deal

    June 9, 2026
  • The inflation surge is hitting businesses, too

    June 15, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock